BindingDB logo
myBDB logout

null

SMILES: COc1cc2nc(N)n3nc(nc3c2cc1F)[C@@H]1CC[C@H](C)N(C1)c1cnn(c1)C1CCC(C)(O)CC1

InChI Key:

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 551551   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Adenosine receptor A2b


(Homo sapiens (Human))
BDBM551551
PNG
(US11312719, Example 97)
Show SMILES COc1cc2nc(N)n3nc(nc3c2cc1F)[C@@H]1CC[C@H](C)N(C1)c1cnn(c1)C1CCC(C)(O)CC1 |r,wD:17.19,20.23,(10.86,-26.5,;9.52,-27.27,;8.19,-26.5,;8.19,-24.96,;6.86,-24.19,;6.86,-22.65,;5.52,-21.88,;5.52,-20.34,;4.19,-22.65,;2.72,-22.17,;1.82,-23.42,;2.72,-24.66,;4.19,-24.19,;5.52,-24.96,;5.52,-26.5,;6.86,-27.27,;6.86,-28.81,;.28,-23.42,;-.49,-24.75,;-2.03,-24.75,;-2.8,-23.42,;-4.34,-23.42,;-2.03,-22.08,;-.49,-22.08,;-2.8,-20.75,;-2.18,-19.34,;-3.32,-18.31,;-4.65,-19.08,;-4.33,-20.59,;-6.06,-18.46,;-6.22,-16.93,;-7.63,-16.3,;-8.87,-17.2,;-9.64,-15.87,;-10.41,-17.2,;-8.71,-18.74,;-7.31,-19.36,)|
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 33.3n/an/an/an/an/an/a


TBA

Assay Description
The reported affinity of the compounds of the invention for the human A2b adenosine receptor was determined experimentally using a radioligand filtra...


Citation and Details

BindingDB Entry DOI: 10.7270/Q2639SZ0
More data for this
Ligand-Target Pair
Adenosine receptor A2a


(Homo sapiens (Human))
BDBM551551
PNG
(US11312719, Example 97)
Show SMILES COc1cc2nc(N)n3nc(nc3c2cc1F)[C@@H]1CC[C@H](C)N(C1)c1cnn(c1)C1CCC(C)(O)CC1 |r,wD:17.19,20.23,(10.86,-26.5,;9.52,-27.27,;8.19,-26.5,;8.19,-24.96,;6.86,-24.19,;6.86,-22.65,;5.52,-21.88,;5.52,-20.34,;4.19,-22.65,;2.72,-22.17,;1.82,-23.42,;2.72,-24.66,;4.19,-24.19,;5.52,-24.96,;5.52,-26.5,;6.86,-27.27,;6.86,-28.81,;.28,-23.42,;-.49,-24.75,;-2.03,-24.75,;-2.8,-23.42,;-4.34,-23.42,;-2.03,-22.08,;-.49,-22.08,;-2.8,-20.75,;-2.18,-19.34,;-3.32,-18.31,;-4.65,-19.08,;-4.33,-20.59,;-6.06,-18.46,;-6.22,-16.93,;-7.63,-16.3,;-8.87,-17.2,;-9.64,-15.87,;-10.41,-17.2,;-8.71,-18.74,;-7.31,-19.36,)|
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.600n/an/an/an/an/an/a


TBA

Assay Description
148 μL (5 μg/mL) membranes (Perkin Elmer, Cat. No. RBHA2aM400UA) and 2 μL compounds of the invention to be tested (test compound) were...


Citation and Details

BindingDB Entry DOI: 10.7270/Q2639SZ0
More data for this
Ligand-Target Pair